carnitine has been researched along with Adrenoleukodystrophy in 5 studies
Adrenoleukodystrophy: An X-linked recessive disorder characterized by the accumulation of saturated very long chain fatty acids in the LYSOSOMES of ADRENAL CORTEX and the white matter of CENTRAL NERVOUS SYSTEM. This disease occurs almost exclusively in the males. Clinical features include the childhood onset of ATAXIA; NEUROBEHAVIORAL MANIFESTATIONS; HYPERPIGMENTATION; ADRENAL INSUFFICIENCY; SEIZURES; MUSCLE SPASTICITY; and DEMENTIA. The slowly progressive adult form is called adrenomyeloneuropathy. The defective gene ABCD1 is located at Xq28, and encodes the adrenoleukodystrophy protein (ATP-BINDING CASSETTE TRANSPORTERS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Elevated blood C24:0- and C26:0-carnitines and lysophosphatidylcholines (LPCs) were reported as diagnostic biomarkers for X-linked adrenoleukodystrophy (X-ALD)." | 7.96 | Evaluation of a panel of very long-chain lysophosphatidylcholines and acylcarnitines for screening of X-linked adrenoleukodystrophy in China. ( Ji, W; Jiang, K; Tian, GL; Wang, YM; Xu, F; Zhuang, YP, 2020) |
| "Elevated blood C24:0- and C26:0-carnitines and lysophosphatidylcholines (LPCs) were reported as diagnostic biomarkers for X-linked adrenoleukodystrophy (X-ALD)." | 3.96 | Evaluation of a panel of very long-chain lysophosphatidylcholines and acylcarnitines for screening of X-linked adrenoleukodystrophy in China. ( Ji, W; Jiang, K; Tian, GL; Wang, YM; Xu, F; Zhuang, YP, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tian, GL | 1 |
| Xu, F | 1 |
| Jiang, K | 1 |
| Wang, YM | 1 |
| Ji, W | 1 |
| Zhuang, YP | 1 |
| Huffnagel, IC | 1 |
| van de Beek, MC | 2 |
| Showers, AL | 1 |
| Orsini, JJ | 1 |
| Klouwer, FCC | 1 |
| Dijkstra, IME | 1 |
| Schielen, PC | 1 |
| van Lenthe, H | 2 |
| Wanders, RJA | 1 |
| Vaz, FM | 2 |
| Morrissey, MA | 1 |
| Engelen, M | 2 |
| Kemp, S | 2 |
| Dijkstra, IM | 1 |
| Ofman, R | 1 |
| Goldhaber-Pasillas, D | 1 |
| Schauer, N | 1 |
| Schackmann, M | 1 |
| Engelen-Lee, JY | 1 |
| Kulik, W | 1 |
| Wanders, RJ | 1 |
| Sandlers, Y | 1 |
| Moser, AB | 2 |
| Hubbard, WC | 1 |
| Kratz, LE | 1 |
| Jones, RO | 1 |
| Raymond, GV | 1 |
| Brown, FR | 1 |
| Van Duyn, MA | 1 |
| Schulman, JD | 1 |
| Rizzo, WB | 1 |
| Snyder, RD | 1 |
| Murphy, JV | 1 |
| Kamoshita, S | 1 |
| Migeon, CJ | 1 |
| Moser, HW | 1 |
5 other studies available for carnitine and Adrenoleukodystrophy
| Article | Year |
|---|---|
Evaluation of a panel of very long-chain lysophosphatidylcholines and acylcarnitines for screening of X-linked adrenoleukodystrophy in China.
Topics: Adrenoleukodystrophy; Age Factors; Biomarkers; Carnitine; Case-Control Studies; Child; Dried Blood S | 2020 |
Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy.
Topics: Adrenoleukodystrophy; Adult; ATP Binding Cassette Transporter, Subfamily D, Member 1; Biomarkers; Ca | 2017 |
C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man.
Topics: Acetyltransferases; Adrenoleukodystrophy; Animals; ATP Binding Cassette Transporter, Subfamily D, Me | 2016 |
Combined extraction of acyl carnitines and 26:0 lysophosphatidylcholine from dried blood spots: prospective newborn screening for X-linked adrenoleukodystrophy.
Topics: Adrenoleukodystrophy; Carnitine; Chromatography, Liquid; Dried Blood Spot Testing; Humans; Infant, N | 2012 |
Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids.
Topics: Adolescent; Adrenoleukodystrophy; Adult; Brain; Carnitine; Clofibrate; Diffuse Cerebral Sclerosis of | 1982 |